INTERNATIONAL PATENT: T-KNIFE GMBH FILES APPLICATION FOR "CHIMERIC HUMAN CD 95 SWITCH RECEPTOR, T-CELL EXPRESSING SAID RECEPTOR TOGETHER WITH AN ENGINEERED T-CELL RECEPTOR, RESPECTIVE VECTORS, KITS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A PATIENT HAVING A DISEASE"

GENEVA, March 9 -- T-KNIFE GMBH (Robert-Roessle-Str. 1013125 Berlin) filed a patent application (PCT/EP2024/073652) for "CHIMERIC HUMAN CD 95 SWITCH RECEPTOR, T-CELL EXPRESSING SAID RECEPTOR TOGETHER WITH AN ENGINEERED T-CELL RECEPTOR, RESPECTIVE VECTORS, KITS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A PATIENT HAVING A DISEASE" on Aug 23, 2024. With publication no. WO/2025/045752, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STEKLOV, Mikhail (c/o T-Knife GmbHRobert-Roessle-Str. 1013125 Berlin), KNIPPING, F...